Cargando…
ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ
ATPase inhibitory factor-1 (IF1) preserves cellular ATP under conditions of respiratory collapse, yet the function of IF1 under normal respiring conditions is unresolved. We tested the hypothesis that IF1 promotes mitochondrial dysfunction and pathological cardiomyocyte hypertrophy in the context of...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122940/ https://www.ncbi.nlm.nih.gov/pubmed/33922643 http://dx.doi.org/10.3390/ijms22094427 |
_version_ | 1783692761093898240 |
---|---|
author | Pavez-Giani, Mario G. Sánchez-Aguilera, Pablo I. Bomer, Nils Miyamoto, Shigeki Booij, Harmen G. Giraldo, Paula Oberdorf-Maass, Silke U. Nijholt, Kirsten T. Yurista, Salva R. Milting, Hendrik van der Meer, Peter de Boer, Rudolf A. Heller Brown, Joan Sillje, Herman W. H. Westenbrink, B. Daan |
author_facet | Pavez-Giani, Mario G. Sánchez-Aguilera, Pablo I. Bomer, Nils Miyamoto, Shigeki Booij, Harmen G. Giraldo, Paula Oberdorf-Maass, Silke U. Nijholt, Kirsten T. Yurista, Salva R. Milting, Hendrik van der Meer, Peter de Boer, Rudolf A. Heller Brown, Joan Sillje, Herman W. H. Westenbrink, B. Daan |
author_sort | Pavez-Giani, Mario G. |
collection | PubMed |
description | ATPase inhibitory factor-1 (IF1) preserves cellular ATP under conditions of respiratory collapse, yet the function of IF1 under normal respiring conditions is unresolved. We tested the hypothesis that IF1 promotes mitochondrial dysfunction and pathological cardiomyocyte hypertrophy in the context of heart failure (HF). Methods and results: Cardiac expression of IF1 was increased in mice and in humans with HF, downstream of neurohumoral signaling pathways and in patterns that resembled the fetal-like gene program. Adenoviral expression of wild-type IF1 in primary cardiomyocytes resulted in pathological hypertrophy and metabolic remodeling as evidenced by enhanced mitochondrial oxidative stress, reduced mitochondrial respiratory capacity, and the augmentation of extramitochondrial glycolysis. Similar perturbations were observed with an IF1 mutant incapable of binding to ATP synthase (E55A mutation), an indication that these effects occurred independent of binding to ATP synthase. Instead, IF1 promoted mitochondrial fragmentation and compromised mitochondrial Ca(2+) handling, which resulted in sarcoplasmic reticulum Ca(2+) overloading. The effects of IF1 on Ca(2+) handling were associated with the cytosolic activation of calcium–calmodulin kinase II (CaMKII) and inhibition of CaMKII or co-expression of catalytically dead CaMKIIδC was sufficient to prevent IF1 induced pathological hypertrophy. Conclusions: IF1 represents a novel member of the fetal-like gene program that contributes to mitochondrial dysfunction and pathological cardiac remodeling in HF. Furthermore, we present evidence for a novel, ATP-synthase-independent, role for IF1 in mitochondrial Ca(2+) handling and mitochondrial-to-nuclear crosstalk involving CaMKII. |
format | Online Article Text |
id | pubmed-8122940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81229402021-05-16 ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ Pavez-Giani, Mario G. Sánchez-Aguilera, Pablo I. Bomer, Nils Miyamoto, Shigeki Booij, Harmen G. Giraldo, Paula Oberdorf-Maass, Silke U. Nijholt, Kirsten T. Yurista, Salva R. Milting, Hendrik van der Meer, Peter de Boer, Rudolf A. Heller Brown, Joan Sillje, Herman W. H. Westenbrink, B. Daan Int J Mol Sci Article ATPase inhibitory factor-1 (IF1) preserves cellular ATP under conditions of respiratory collapse, yet the function of IF1 under normal respiring conditions is unresolved. We tested the hypothesis that IF1 promotes mitochondrial dysfunction and pathological cardiomyocyte hypertrophy in the context of heart failure (HF). Methods and results: Cardiac expression of IF1 was increased in mice and in humans with HF, downstream of neurohumoral signaling pathways and in patterns that resembled the fetal-like gene program. Adenoviral expression of wild-type IF1 in primary cardiomyocytes resulted in pathological hypertrophy and metabolic remodeling as evidenced by enhanced mitochondrial oxidative stress, reduced mitochondrial respiratory capacity, and the augmentation of extramitochondrial glycolysis. Similar perturbations were observed with an IF1 mutant incapable of binding to ATP synthase (E55A mutation), an indication that these effects occurred independent of binding to ATP synthase. Instead, IF1 promoted mitochondrial fragmentation and compromised mitochondrial Ca(2+) handling, which resulted in sarcoplasmic reticulum Ca(2+) overloading. The effects of IF1 on Ca(2+) handling were associated with the cytosolic activation of calcium–calmodulin kinase II (CaMKII) and inhibition of CaMKII or co-expression of catalytically dead CaMKIIδC was sufficient to prevent IF1 induced pathological hypertrophy. Conclusions: IF1 represents a novel member of the fetal-like gene program that contributes to mitochondrial dysfunction and pathological cardiac remodeling in HF. Furthermore, we present evidence for a novel, ATP-synthase-independent, role for IF1 in mitochondrial Ca(2+) handling and mitochondrial-to-nuclear crosstalk involving CaMKII. MDPI 2021-04-23 /pmc/articles/PMC8122940/ /pubmed/33922643 http://dx.doi.org/10.3390/ijms22094427 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pavez-Giani, Mario G. Sánchez-Aguilera, Pablo I. Bomer, Nils Miyamoto, Shigeki Booij, Harmen G. Giraldo, Paula Oberdorf-Maass, Silke U. Nijholt, Kirsten T. Yurista, Salva R. Milting, Hendrik van der Meer, Peter de Boer, Rudolf A. Heller Brown, Joan Sillje, Herman W. H. Westenbrink, B. Daan ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ |
title | ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ |
title_full | ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ |
title_fullStr | ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ |
title_full_unstemmed | ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ |
title_short | ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ |
title_sort | atpase inhibitory factor-1 disrupts mitochondrial ca(2+) handling and promotes pathological cardiac hypertrophy through camkiiδ |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122940/ https://www.ncbi.nlm.nih.gov/pubmed/33922643 http://dx.doi.org/10.3390/ijms22094427 |
work_keys_str_mv | AT pavezgianimariog atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT sanchezaguilerapabloi atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT bomernils atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT miyamotoshigeki atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT booijharmeng atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT giraldopaula atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT oberdorfmaasssilkeu atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT nijholtkirstent atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT yuristasalvar atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT miltinghendrik atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT vandermeerpeter atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT deboerrudolfa atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT hellerbrownjoan atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT silljehermanwh atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid AT westenbrinkbdaan atpaseinhibitoryfactor1disruptsmitochondrialca2handlingandpromotespathologicalcardiachypertrophythroughcamkiid |